In the months after Pfizer’s experimental COVID-19 injection was authorized in the U.S., Pfizer hired 600 more employees. Why? Because of the massive increase in adverse events linked to the injection. This is not hearsay or conspiracy. It comes directly from Pfizer’s own documents made public because of a Freedom of Information Act (FOIA) request. You can find this information easily for yourself online, where many news sources have reported it.
That is, if you can handle facts you may not want to hear.
The document, titled “5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021,” was approved by the FDA on August 23, 2021. It was not made public until a group called Public Health and Medical Professionals for Transparency sued the FDA to have documents relating to the emergency use authorization granted to Pfizer released to public view.
In an April op-ed, Daniel Horowitz of Blaze Media uncovered three important findings from the documents, which unequivocally affirm that the pharma/government narrative was a lie at its very core. Some findings:
- Pfizer needed many more staff members to process adverse event reports.
The Pfizer document says there were 42,086 adverse events voluntarily reported to the company — and 1,223 were fatalities as of February 28, 2021. That is a huge and horrifying number of adverse event reports and fatalities which the government and Pfizer hoped not to report to the public for 75 years.
A new, unredacted copy of the document details nine pages of several thousand known categories of adverse effects, revealing the massive scope of injuries being reported to Pfizer. This raises questions in any reasonable person’s mind as to what Pfizer knew, when they knew it, and what they have observed in the ensuing months? Those have yet to be answered.
In the document, Pfizer reveals that “due to the large numbers of spontaneous adverse event reports,” the company had to hire approximately 600 full-time employees (FTEs). And Pfizer expected more than 1,800 additional hires by the end of June 2021.
How many people would have taken Pfizer’s injection had they known this, and how is the failure to disclose this information not a clear violation of the Nuremberg Code? What else did Pfizer discover in the ensuing months? What else are they not disclosing to the public even now?
Maybe they should come clean instead of waiting for the next FOIA request.
- The rate of myocarditis is skyrocketing.
It became apparent to the public earlier in 2021 that myocarditis was a known side effect of the injections. The federal government and their compliant mainstream media foot soldiers immediately started a false narrative that the incidence rate was minuscule. “Nothing to see here, folks.” “Extremely rare.”
Some uncreditable “studies” tried to downplay the risks. One from Kaiser Permanente in JAMA said the rate was only 6.6 per million; another JAMA study suggested the rate was 1 in 50,000 among military service members. We now know that this rate is significantly underreported.
The Informed Consent Action Network’s FOIA request (and resulting legal suit) revealed that Pfizer was documenting the risk to be as high as 1 in 1,000. All these fairy tales about young males being at greater health risk from the virus than from the injections are pure nonsense — wishful thinking, deliberate ignorance. And if this is what Pfizer is willing to concede, can you imagine what the true incidence rate of heart problems is?
Furthermore, what is the extent of subclinical (that is, yet-to-be-diagnosed) myocarditis? If these many cases appeared shortly after the injection, how large is the cohort of people with heart damage that has remained subclinical thus far? Consider that far fewer injections are being administered in 2022 — yet the rate of myocarditis reports to VAERS is skyrocketing at 295 percent greater than in 2021.
Where are our protectors in the FDA? Asleep at the wheel, it seems.
The FDA begged ignorance about subclinical myocarditis and long-term heart damage. The beleaguered agency conceded in the Pharmacovigilance Plan Review Addendum for Comirnaty, “Incidence of subclinical myocarditis and potential long-term sequelae following Comirnaty are unknown.” Great. So the FDA greenlighted a potential genocide on young men who had virtually zero risk of dying of COVID. The FDA did note that a previous study on a smallpox vaccine “suggested an incidence of possible subclinical myocarditis 60 times higher than the incidence rate of overt clinical myocarditis.” Applying this to the COVID injections would take the rate of subclinical myocarditis down from 1 in 1,000 in young males to 1 in 17.
As heartbreaking as it is to contemplate, many young males are walking around as ticking time bombs.
The FDA stated, “Based on review of available data, there are known risks for myocarditis and pericarditis and an unexpected serious risk for subclinical myocarditis, which warrant Postmarketing Requirement safety studies to assess these serious risks.” They requested Comirnaty (Pfizer-BioNTech) to conduct studies but noted their requests were rebuffed. More than seven months after their full approval, we still have no studies.
Here’s one idea: How about the government conducts cardiac MRIs to screen for scarring in young men? This would help us get a picture of what has actually occurred in the wake of this drug.
- Pfizer knew about the superior efficacy of natural immunity and failed to make it known to the public.
Pfizer never studied the efficacy of its injections exclusively for those who had recovered from prior COVID infection, which would have helped demonstrate the efficacy — or lack of it — of natural immunity. Rather, Pfizer combined results of those with and without prior COVID infection. However, they did break down results in a way that clearly indicates that those with natural immunity had no need for the injections. Without diving into the arcana of those numbers — you may do so on your own, as the documents are now public — I will say they show that those with prior infection (meaning natural immunity) had zero cases of serious infection in both the trial and placebo groups.
In other words, Pfizer knew people with natural immunity didn’t need the injection, but the company promoted it vigorously and received approval from the FDA regardless of one’s natural immunity.
Our nation — indeed, the globe — is in the beginning stages of assessing what actually happened with the rushed approval and mass promotion of these relatively unproven and novel gene therapy injections. Someday we will know more fully what Pfizer, and the FDA, knew and when. But even now, the facts are coming to light — indicating that hundreds of millions of people may have been subjected to the largest medical experiment in the history of mankind.